Related references
Note: Only part of the references are listed.Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer
Wout Devlies et al.
CANCERS (2021)
Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers
John W. Phillips et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer
Dingxiao Zhang et al.
NATURE COMMUNICATIONS (2020)
Neddylation inactivation represses androgen receptor transcription and inhibits growth, survival and invasion of prostate cancer cells
Xiaochen Zhou et al.
NEOPLASIA (2020)
SynergyFinder 2.0: visual analytics of multi-drug combination synergies
Aleksandr Ianevski et al.
NUCLEIC ACIDS RESEARCH (2020)
Nuclear β-catenin expression is positively regulated by JAB1 in human colorectal cancer cells
Arata Nishimoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
The pivotal oncogenic role of Jab1/CSN5 and its therapeutic implications in human cancer
Zhen Guo et al.
GENE (2019)
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)
Ying Z. Mazzu et al.
CLINICAL CANCER RESEARCH (2019)
c-MYC empowers transcription and productive splicing of the oncogenic splicing factor Sam68 in cancer
Cinzia Caggiano et al.
NUCLEIC ACIDS RESEARCH (2019)
Genomic correlates of clinical outcome in advanced prostate cancer
Wassim Abida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem Cells
Gianluca Civenni et al.
FRONTIERS IN ONCOLOGY (2019)
CUT&Tag for efficient epigenomic profiling of small samples and single cells
Hatice S. Kaya-Okur et al.
NATURE COMMUNICATIONS (2019)
JAB1/COPS5 is a putative oncogene that controls critical oncoproteins deregulated in prostate cancer
David Danielpour et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer
Justin H. Hwang et al.
CELL REPORTS (2019)
The long tail of oncogenic drivers in prostate cancer
Joshua Armenia et al.
NATURE GENETICS (2018)
Jabl/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer
Guohong Liu et al.
FRONTIERS IN PHARMACOLOGY (2018)
The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer
Ettaib El Marabti et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2018)
Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy
Shuang G. Zhao et al.
JAMA ONCOLOGY (2017)
Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes
A. Sveen et al.
ONCOGENE (2016)
Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome
Sungyong You et al.
CANCER RESEARCH (2016)
COPS5 amplification and overexpression confers tamoxifen-resistance in ERα-positive breast cancer by degradation of NCoR
Renquan Lu et al.
NATURE COMMUNICATIONS (2016)
Efficacy of Enzalutamide Following Abiraterone Acetate in Chemotherapy- naive Metastatic Castration-resistant Prostate Cancer Patients
Arun A. Azad et al.
EUROPEAN UROLOGY (2015)
Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens
Torsten Nielsen et al.
BMC CANCER (2014)
Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer
Yunbao Pan et al.
CANCER BIOLOGY & THERAPY (2014)
Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)
Y. Loriot et al.
ANNALS OF ONCOLOGY (2013)
Punctuated Evolution of Prostate Cancer Genomes
Sylvan C. Baca et al.
CELL (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Homeostasis and the Importance for a Balance Between AKT/mTOR Activity and Intracellular Signaling
D. A. Altomare et al.
CURRENT MEDICINAL CHEMISTRY (2012)
mTOR links oncogenic signaling to tumor cell metabolism
Jessica L. Yecies et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
The genomic complexity of primary human prostate cancer
Michael F. Berger et al.
NATURE (2011)
Targeting SP1 Transcription Factor in Prostate Cancer Therapy
Umesh T. Sankpal et al.
Medicinal Chemistry (2011)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
Upstream Stimulatory Factor 2, a Novel FoxA1-Interacting Protein, Is Involved in Prostate-Specific Gene Expression
Qian Sun et al.
MOLECULAR ENDOCRINOLOGY (2009)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression
Adam S. Adler et al.
CANCER RESEARCH (2008)
Targeting the androgen receptor pathway in prostate cancer
Yu Chen et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Genetic regulators of large-scale transcriptional signatures in cancer
AS Adler et al.
NATURE GENETICS (2006)
Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis
HI Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Hey1, a mediator of notch signaling, is an androgen receptor corepressor
B Belandia et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Function and regulation of Cullin-RING ubiquitin ligases
MD Petroski et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
From polyploidy to aneuploidy, genome instability and cancer
Z Storchova et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
ONCOMINE: A cancer microarray database and integrated data-mining platform
DR Rhodes et al.
NEOPLASIA (2004)
JAB1 interacts with both the progesterone receptor and SRC-1
A Chauchereau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
8p22 loss concurrent with 8c gain is associated with poor outcome in prostate cancer
JA Macoska et al.
UROLOGY (2000)
Share Paper
